Biotechnology company Amgen reported total revenues of around 28.2 billion U.S. dollars in 2022, increasing by approximately 1.9 billion U.S. dollars compared to the previous year.
The U.S. is Amgen’s largest market
Amgen focuses on the development and manufacture of human therapeutics for the treatment of serious illnesses. The company markets its products around the world, but most sales are made within the United States: more than 70 percent of the company’s product revenues are generated in the country. The majority of product sales in the United States were made to three pharmaceutical wholesalers: Cardinal Health, AmerisourceBergen Corporation, and McKesson Corporation. These wholesalers buy drugs in bulk and then sell them to their customers, which include hospitals, clinics, and pharmacies.
Beware of the copycats
Amgen's Enbrel, a drug sold in North America that is used to treat rheumatoid arthritis, lost its position as the company's best-selling product. Launched in 1998, the exclusivity of the drug has come under pressure in recent years, with a growing number of companies announcing that they are developing biosimilar versions of the product. Amgen has been involved in patent litigations with two companies (Samsung Bioepis and Novartis Sandoz) seeking to market their own versions of the drug, which have been approved by the U.S. Food and Drug Administration.
Total revenue of biotech company Amgen from 2004 to 2023
(in million U.S. dollars)
Characteristic
Revenue in million U.S. dollars
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Exclusive Premium Statistic
To access all Premium Statistics, you need a paid Statista Account
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Amgen. (February 14, 2024). Total revenue of biotech company Amgen from 2004 to 2023 (in million U.S. dollars) [Graph]. In Statista. Retrieved September 01, 2024, from https://www.statista.com/statistics/265856/revenues-of-amgen-since-2004/
Amgen. "Total revenue of biotech company Amgen from 2004 to 2023 (in million U.S. dollars)." Chart. February 14, 2024. Statista. Accessed September 01, 2024. https://www.statista.com/statistics/265856/revenues-of-amgen-since-2004/
Amgen. (2024). Total revenue of biotech company Amgen from 2004 to 2023 (in million U.S. dollars). Statista. Statista Inc.. Accessed: September 01, 2024. https://www.statista.com/statistics/265856/revenues-of-amgen-since-2004/
Amgen. "Total Revenue of Biotech Company Amgen from 2004 to 2023 (in Million U.S. Dollars)." Statista, Statista Inc., 14 Feb 2024, https://www.statista.com/statistics/265856/revenues-of-amgen-since-2004/
Amgen, Total revenue of biotech company Amgen from 2004 to 2023 (in million U.S. dollars) Statista, https://www.statista.com/statistics/265856/revenues-of-amgen-since-2004/ (last visited September 01, 2024)
Total revenue of biotech company Amgen from 2004 to 2023 (in million U.S. dollars) [Graph], Amgen, February 14, 2024. [Online]. Available: https://www.statista.com/statistics/265856/revenues-of-amgen-since-2004/